Lisinopril-Induced Liver Injury: An Unusual Presentation and Literature Review
Lisinopril is an angiotensin converting enzyme inhibitor (ACE-I) that has been on market for more than 25 years. ACE-I are usually well tolerated and rarely have serious or life-threatening side effects. We describe an unusual presentation of fulminant hepatic cholestasis probably secondary to lisin...
Main Authors: | Ammar Al-Rifaie, Mir Azam Khan, Amjad Ali, Asha Kumari Dube, Dermot Gleeson, Barbara Hoeroldt |
---|---|
Format: | Article |
Language: | English |
Published: |
SMC MEDIA SRL
2020-04-01
|
Series: | European Journal of Case Reports in Internal Medicine |
Subjects: | |
Online Access: | https://www.ejcrim.com/index.php/EJCRIM/article/view/1600 |
Similar Items
-
Angiotensin-converting enzyme inhibition by lisinopril enhances liver regeneration in rats
by: F.S. Ramalho, et al.
Published: (2001-01-01) -
Angiotensin Converting Enzyme Inhibitor-related Angioedema: A Case of an Unexpected Death
by: Eray Atalay, et al.
Published: (2015-11-01) -
A rare presentation of angioedema with isolated retropharyngeal and supraglottic involvement
by: H. Patel, et al.
Published: (2019-01-01) -
A fixed-dose lisinopril and amlodipine combination in conjunction with rosuvastatin in patients with hypertensive disease and coronary heart disease
by: Z M Galeeva, et al.
Published: (2014-09-01) -
SOME ASPECTS OF THE LISINOPRIL USAGE IN ARTERIAL HYPERTENSION TREATMENT
by: N. A. Jaiani
Published: (2016-01-01)